0001172661-21-000387.txt : 20210212
0001172661-21-000387.hdr.sgml : 20210212
20210212162150
ACCESSION NUMBER: 0001172661-21-000387
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20201231
FILED AS OF DATE: 20210212
DATE AS OF CHANGE: 20210212
EFFECTIVENESS DATE: 20210212
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Summit Rock Advisors, LP
CENTRAL INDEX KEY: 0001540951
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-14655
FILM NUMBER: 21627840
BUSINESS ADDRESS:
STREET 1: 9 WEST 57TH STREET, 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 212-993-7138
MAIL ADDRESS:
STREET 1: 9 WEST 57TH STREET, 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
FORMER COMPANY:
FORMER CONFORMED NAME: Summit Rock Advisors, LLC
DATE OF NAME CHANGE: 20120131
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
true
false
0001540951
XXXXXXXX
12-31-2020
12-31-2020
false
Summit Rock Advisors, LP
9 West 57th Street, 12th Floor
New York
NY
10019
13F HOLDINGS REPORT
028-14655
N
Emily Locher
Chief Compliance Officer
212-993-7180
/s/ Emily Locher
New York
NY
02-12-2021
0
10
286745
INFORMATION TABLE
2
infotable.xml
AKERO THERAPEUTICS INC
COM
00973Y108
384
14891
SH
SOLE
14891
0
0
GENERATION BIO CO
COM
37148K100
258
9113
SH
SOLE
9113
0
0
INVESCO EXCH TRADED FD TR II
SR LN ETF
46138G508
10409
467191
SH
SOLE
467191
0
0
ISHARES TR
CONV BD ETF
46435G102
16631
172253
SH
SOLE
172253
0
0
ISHARES TR
CORE S&P US VLU
464287663
45175
726403
SH
SOLE
726403
0
0
ISHARES TR
IBOXX HI YD ETF
464288513
36181
414440
SH
SOLE
414440
0
0
PHATHOM PHARMACEUTICALS INC
COM
71722W107
1141
34350
SH
SOLE
34350
0
0
VANGUARD INTL EQUITY INDEX F
FTSE SMCAP ETF
922042718
59429
487765
SH
SOLE
487765
0
0
VANGUARD INTL EQUITY INDEX F
TT WRLD ST ETF
922042742
102246
1104408
SH
SOLE
1104408
0
0
VANGUARD WORLD FD
EXTENDED DUR
921910709
14891
97773
SH
SOLE
97773
0
0